Omicron: what makes the latest SARS-CoV-2 variant of concern so concerning?

C Jung, D Kmiec, L Koepke, F Zech, T Jacob… - Journal of …, 2022 - Am Soc Microbiol
Emerging strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the
causative agent of the coronavirus disease 2019 (COVID-19) pandemic, that show …

Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency

T Acter, N Uddin, J Das, A Akhter, TR Choudhury… - Science of the Total …, 2020 - Elsevier
According to data compiled by researchers at Johns Hopkins University in Baltimore,
Maryland, more than two and half million cases of coronavirus disease 2019 (COVID-19) …

COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies

K Rawat, P Kumari, L Saha - European journal of pharmacology, 2021 - Elsevier
Coronavirus Disease 2019 named as COVID-19 imposing a huge burden on public health
as well as global economies, is caused by a new strain of betacoronavirus named as SARS …

Susceptibility of white-tailed deer (Odocoileus virginianus) to SARS-CoV-2

MV Palmer, M Martins, S Falkenberg, A Buckley… - Journal of …, 2021 - Am Soc Microbiol
The origin of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus
causing the global coronavirus disease 2019 (COVID-19) pandemic, remains a mystery …

Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV

KG Lokugamage, A Hage, M de Vries… - Journal of …, 2020 - Am Soc Microbiol
ABSTRACT SARS-CoV-2, a novel coronavirus (CoV) that causes COVID-19, has recently
emerged causing an ongoing outbreak of viral pneumonia around the world. While distinct …

[HTML][HTML] Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease

P Zhou, G Song, H Liu, M Yuan, W He, N Beutler, X Zhu… - Immunity, 2023 - cell.com
Pan-betacoronavirus neutralizing antibodies may hold the key to develo** broadly
protective vaccines against novel pandemic coronaviruses and to more effectively respond …

Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin …

C Mouffouk, S Mouffouk, S Mouffouk… - European journal of …, 2021 - Elsevier
The novel coronavirus outbreak (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) represents the actual greatest global public health crisis. The …

Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology

N Deigendesch, L Sironi, M Kutza, S Wischnewski… - Acta …, 2020 - Springer
Infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily
lead to upper respiratory tract infection and its sequelae frequently dominate the clinical …

Antiviral activity of type I, II, and III interferons counterbalances ACE2 inducibility and restricts SARS-CoV-2

I Busnadiego, S Fernbach, MO Pohl, U Karakus… - MBio, 2020 - Am Soc Microbiol
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus
disease 2019 (COVID-19), is a recently emerged respiratory coronavirus that has infected> …

Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development

SK Samrat, AM Tharappel, Z Li, H Li - Virus research, 2020 - Elsevier
The recent outbreak of the betacoronavirus SARS-CoV-2 has become a significant concern
to public health care worldwide. As of August 19, 2020, more than 22,140,472 people are …